Walleye Capital’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
25,131
-133,304
| -84% | -$6.48M | ﹤0.01% | 773 |
|
|
2025
Q1 | $5.39M | Buy |
158,435
+142,908
| +920% | +$4.86M | 0.02% | 336 |
|
|
2024
Q4 | $611K | Buy |
15,527
+15,122
| +3,734% | +$595K | ﹤0.01% | 1102 |
|
|
2024
Q3 | $19K | Sell |
405
-331
| -45% | -$15.6K | ﹤0.01% | 2128 |
|
|
2024
Q2 | $39.8K | Buy |
736
+144
| +24% | +$7.78K | ﹤0.01% | 2193 |
|
|
2024
Q1 | $40.4K | Buy |
+592
| New | +$40.4K | ﹤0.01% | 2156 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2329 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2406 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2230 |
|
|
2023
Q1 | – | Sell |
-32,358
| Closed | -$1.32M | – | 2245 |
|
|
2022
Q4 | $1.32M | Buy |
+32,358
| New | +$1.32M | 0.02% | 604 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2359 |
|
|
2019
Q4 | – | Sell |
-1,555
| Closed | -$64K | – | 744 |
|
|
2019
Q3 | $64K | Buy |
+1,555
| New | +$64K | ﹤0.01% | 327 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 577 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 427 |
|